Factores pronósticos de sobrevida quinquenal de pacientes con carcinoma gástrico

Rev. Gastroenterol. Perú 2003; 23 (3): 184-191

FACTORES PRONÓSTICOS DE SOBREVIDA QUINQUENAL DE PACIENTES CON CARCINOMA GÁSTRICO AVANZADO RESECABLE CON SEROSA EXPUESTA

BIBLIOGRAFÍA

1. ALBÚJAR P. El Cáncer en Trujillo, 1991-1995. Estudio de incidencia y mortalidad. Registro de Base Poblacional de la ciudad de Trujillo-Perú. Concytec. Monografía Nro 3. Trujillo 2000; 17.

2. BARBOZA E. Cáncer de estómago. Rev Med Hered 1996; 7: 87-100.

3. DÍAZ-PLASENCIA J, RAZÚRI-ARAUJO R. Factores pronósticos de sobrevida en cáncer gástrico con ganglios regionales negativos. Rev Gastroent Peru 1999; 19: 26-34.

4. KURTZ R, SHERLOCK P. The diagnoses of gastric cancer. Semin Oncol 1985; 12: 11-8.

5. YAMASAKI H, OSHIMA A, MURAKAMI R, ENDO S, UBUKATA T. A long-term follow-up study of patients with gastric cancer detected by mass screening. Cancer 1989; 63: 613-7.

6. LONGO WE, ZUCKER KA, ZDON MJ, MODLIN IM. Detection of early gastric cancer in aggressive endoscopy unit. The American Surgeon 1989; 55: 100-4.

7. ZILIOTTO JRA. Evolutive and prognostic aspects in gastric cancer: analysis of 189 cases. Cancer 1987; 39: 811-7.

8. MORIGUCHI S, MAEHARA Y, KORENAGA D, et al. Relationship between age and the time surgery and prognosis after gastrectomy for gastric cancer. J Surg Oncol 1993; 52: 119-123.

9. OKA M, YOSHINO S, HAZAMA S, et al. Prognostic significance of regional lymph node reaction after curative resection of advanced gastric cancer. Br J Surg 1992; 79: 1091-94.

10. MARUYAMA K. Results of surgery correlated with staging. In: Preece PE, Cuschiere A, Wellwood JM (eds). Cancer of the stomach. London: Grune and Strution; 1986.p. 145-63.

11. CURTIS RE, KENNEDY BJ, MYERS MH, HANKEY BF. Evaluation of AJC stomach cancer staging use the SEER population. Semin Oncol 1985; 12: 21-31.

12. NAKAZATO H, KATO O, YAMAUCHI M, YAMADA E. An analysis of prognostic variables in gastric cancer patients treated surgically. J Jpn Soc Cancer Ther 1981; 16: 121-3.

13. BOKU T, NAKANE Y, MINOURA T, TAKADA H, YAMAMURA M, HIOKI K, YAMAMOTO M. Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg 1990; 77: 436- 439.

14. MARUYAMA K. The most important prognostic factors for gastric cancer patients. A study using univariate and multivariate analyses. Scand J Gastroenterol 1987; 22 (Suppl 133): 63-8.

15. RUIZ E, QUISPE D, CELIS J, BERROSPI F, PAYET E. Cáncer gástrico con invasión hasta la muscular propia. Rev Gastroent Peru 2001; 21: 102-106.

16. International Union Against Cancer. TNM - Classification of malignant tumors. En: Sobin LH, Wittekind Ch, Eds. Stomach. 5th. ed. New York : Willy - Liss; 1997. p. 59 - 62.

17. BORRMANN R. Gesch wulste des magens und duodenums. In : Honke F, Lubarsh O. Hanbuch der speziellen pathologischen anatomic und histologic. Berlin : J Springer; 1926. p. 812 - 1054.

18. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma. 2sd. ed. Tokyo : Kanehara and Co; 1998. p. 10-24.

19. LAUREN P. The two histology main types of gastric carcinoma : Diffuse and so - called intestinal type carcinoma : An attempt at histo - clinical classification. Acta Pathol Microbial Scand 1965; 64 : 31 - 49.

20. RUIZ E, QUISPE D, CELLS J, BERROSPI F, PAYET E. Cáncer gástrico con invasión hasta la muscular propia. Rev Gastroent Peru 2001; 21: 102-106.

21. MAEHARA Y, OSHIRO T, OIWA H, ODA S, BABA H, AKAZAWA K, et al. Gastric carcinoma in patients over 70 years of age. Br J Surg 1995; 82: 102 - 105.

22. ALLGAYER H, HEISS MM, SCHILDBERG FW. Prognostic factors in gastric cancer. British Journal of Surgery 1997; 84: 1651-1664.

23. MAEHARA Y, WATANABE A, KAKEJI Y, EMI Y, MORIGUCHI S, ANAI H, et al. Prognosis for surgically treated gastric cancer patients is poorer for women than men in all patients under age 50. Br J Cancer 1992; 65: 417 - 20.

24. SÁNCHEZ-BUENO F, GARCÍA-MARCILLA JA, PÉREZ-FLORES D, PÉREZ-ABAD JM, VICENTE R, ARANDA F, RAMÍREZ P, PARRILLA P. Prognostic factors in a series of 297 patients with gastric adenocarcinoma undergoing surgical resection. Br J Surg 1998; 85 : 255 - 60.

25. SIEWERT JR, BOTTCHER K, STEIN HJ, et al. Relevant prognostic factors in gastric cancer 1998; Annals of surgery 1998; 228: 449-461.

26. HAUGSTVEDT TK, VISTE A, EIDE GE, et al. Norwegian multicentre study of survival and prognostic factors in patients undergoing curative resection for advanced gastric carcinoma. J Clin Gastroenterol 1995; 21:208-10.

27. MORIGUCHI S, MAEHARA Y, KORENAGA D, et al. Prediction of survival time after curative surgery for advanced gastric cancer. Eur J Surg Oncol 1992; 18:287-92.

28. MORIGUCHI S, MAEHARA Y, KORENAGA D, et al. Relationship between age and the time of surgery and prognosis after gastrectomy for gastric cancer. J Surg Oncol 1993; 52: 119-123.

29. KIM DY, KIM HR, KIM YJ, KIM SK. Clinicopathological features of patients with Borrmann type IV gastric carcinoma. ANZ J Surg 2002; 72: 739-742.

30. MICHELASSI F, TAKANISHI DM JR, PANLATONE D, HART J, CHAPELL R, BLOCK GE. Analysis of clinicopathologic prognostic features in patients with gastric adenocarcinoma. Surgery 1994: 116: 804 - 10.

31. SALVON-HARMAN JC, CADY B, NIKULASSON S, KHETTRY U, STONE MD, LAVIN P. Shifting proportions of gastric adenocarcinomas. Arch Surg 1994; 129 : 381- 9.

32. LEÓN BARÚA R, RECAVARREN-ARCE S, GILMAN RH, BERENDSON R. Can eradication of Helicobacter pylori prevent gastric cancer?. Drugs 1993; 46: 341-346.

33. KARPEH MS, LEON L, KLIMSTRA D, BRENNAN MF. Lymph node staging in gastric cancer: is location more important than number?. Annals of Surgery 2000; 232: 362-371.

34. ARVEUX P, FAIORE J, BOUTRON MC, PIARD F, DUSSURRE - GUION L, MONNET E, et al. Prognosis of gastric carcinoma after curative surgery. A population based study using multivariate crude and relative survival analysis. Dig Dis Sci 1992; 37: 757 - 63.

35. SHIU MH, PERROTTI M, BRENNAN MF. Adenocarcinoma of the stomach: a multivariate analysis of clinical, pathologic and treatment factors. Hepatogastroenterology 1989; 36 : 7 -12.

36. ADACHI Y, KAMATURA T, MORI M, BABA H, MAEHARA Y, SUGIMACHI K. Prognostic significance of the number positive lymph nodes in gastric carcinoma. Br J Surg 1994; 81: 414-16.

37. CLENDENES ALVARADO D, COK GARCÍA J, BUSSALLEU RIVERA A. Tipos histológicos de cáncer gástrico de acuerdo a la clasificación de Lauren en el Hospital Nacional Cayetano Heredia. Rev Gastroent Peru 1995; 15: 239-246.

38. HARAGUCHI M, WATANABE A, KAKEJI Y, et al. Prognostic significance of serosal invasión in carcinoma of the stomach. Surg Gynecol Obstet 1991; 172: 29-32.

39. KINOSHITA T, MARUYAMA K, SASAKO M, OKAJIMA K. Treatment results of gastric cancer patients: Japanese experience. In: Nishi M, Ichikawa H, Nakajima T, eds. Gastric cancer. Tokyo: Springer-Verlag; 1993: 319-330.

40. AKOH J, MACINTYRE I. Mejora de la supervivencia en el cáncer gástrico: Revisión de las tasas de supervivencia a 5 años en publicaciones en lengua inglesa desde 1970. Br J Surg 1992; 79: 293-299.

41. ADACHI Y, KAMAKURA T, MORI M, MAEHARA Y, SUGIMACHI K. Role of lymph node disecction and splenectomy in node-positive gastric carcinoma. Surgery 1994; 116: 837-841.

42. KODAMA Y,SUGIMACHI K, SOEJIMA K, et al. Evaluation of extensive lymph node dissection for carcinoma of the stomach. World J Surg 1981; 5: 241-248.

Regresar